Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Razvan Gheorghita Mares"'
Autor:
Razvan Gheorghita MARES, Doina MANU, Istvan Adorjan SZABO, Mihaela Elena TOMUT, Gabriela PINTICAN, Bogdan CORDOS, Gabriel JAKOBSSON, Minodora DOBREANU, Ovidiu Simion COTOI, Alexandru SCHIOPU
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 3, Pp 573-585 (2021)
The reduction in mortality following acute myocardial infarction (AMI) is an important achievement of modern medicine. Despite this progress, AMI remains the most common cause of heart failure (HF) and HF-related morbidity and mortality. The involvem
Externí odkaz:
https://doaj.org/article/d5216272cf7a47938a4391caa59ee8f9
Autor:
Alexandra Iulia Stoica, Marius Mihai Harpa, Cosmin Marian Banceu, Claudiu Ghiragosian, Carmen Elena Opris, Hussam Al-Hussein, Hamida Al-Hussein, Sanziana Flamind Oltean, Tibor Mezei, Razvan Gheorghita Mares, Horatiu Suciu
Publikováno v:
Medicina, Vol 58, Iss 8, p 1009 (2022)
Cardiac undifferentiated pleomorphic sarcoma (UPS) associated with fever and inflammatory response is an extremely rare condition. Herein, we report a rare case of cardiac UPS with unusual clinical presentation and inflammatory response. A 67-year-ol
Externí odkaz:
https://doaj.org/article/55c34f564c8945bdb454d4264e7cb36a
Autor:
Raluca Maria Boteanu, Viorel-Iulian Suica, Elena Uyy, Luminita Ivan, Aurel Cerveanu-Hogas, Razvan Gheorghita Mares, Maya Simionescu, Alexandru Schiopu, Felicia Antohe
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 9, p 5289 (2022)
Prognosis after myocardial infarction (MI) varies greatly depending on the extent of damaged area and the management of biological processes during recovery. Reportedly, the inhibition of the pro-inflammatory S100A9 reduces myocardial damage after MI
Externí odkaz:
https://doaj.org/article/b0ffa369fbea454599ea818a35ccb007
Autor:
Doina Ramona Manu, Gabriel Jakobsson, Alexandru Schiopu, Mihaela Elena Tomut, Minodora Dobreanu, Bogdan Cordos, Razvan Gheorghita Mares, Ovidiu Simion Cotoi, Istvan Adorjan Szabo, Gabriela Pintican
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 3, Pp 573-585 (2021)
The reduction in mortality following acute myocardial infarction (AMI) is an important achievement of modern medicine. Despite this progress, AMI remains the most common cause of heart failure (HF) and HF-related morbidity and mortality. The involvem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf7e4dd672f3e346284a14909113b42
https://doi.org/10.47803/rjc.2021.31.3.573
https://doi.org/10.47803/rjc.2021.31.3.573
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 26, Iss 1, Pp 9-20 (2018)
Acute myocardial infarction (AMI) is a disease associated with high morbidity and mortality. Currently there are no available treatments specifically targeting the post-ischemic myocardial processes that lead to heart failure and recurrent coronary e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a539521686cf915fcf6f1f49124011f
https://doi.org/10.1515/rrlm-2017-0031
https://doi.org/10.1515/rrlm-2017-0031
Autor:
Matthew Weiland, Lukas Tomas, Razvan Gheorghita Mares, Alexandru Schiopu, Helena Grauen Larsen, Jan Nilsson, Stefan Jovinge, Isabel Gonçalves, Troels Yndigegn, Istvan Adorjan Szabo, Goran Marinković, Lisa de Camp
Publikováno v:
Eur Heart J
Aims Neutrophils have both detrimental and beneficial effects in myocardial infarction (MI), but little is known about the underlying pathways. S100A8/A9 is a pro-inflammatory alarmin abundantly expressed in neutrophils that is rapidly released in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fdecb7ff128afeccf36d256827e654
https://pubmed.ncbi.nlm.nih.gov/31334753
https://pubmed.ncbi.nlm.nih.gov/31334753
Autor:
Razvan Gheorghita Mares, Goran Marinković, Jan Nilsson, Helena Grufman, Troels Yndigegn, Helena Grauen Larsen, Isabel Gonçalves, Alexandru Schiopu
Publikováno v:
Atherosclerosis. 287
Background and aims The pro-inflammatory alarmin S100A12 (EN-RAGE) and the soluble form of its receptor, the receptor for advanced glycation endproducts (sRAGE), have diverging roles in cardiovascular disease. In experimental studies, S100A12 promote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5b489f02f1e68dea18d491b7f0a17b
https://pubmed.ncbi.nlm.nih.gov/31181415
https://pubmed.ncbi.nlm.nih.gov/31181415
Autor:
Goran Marinković, Razvan Gheorghita Mares, Jan-Åke Nilsson, Alexandru Schiopu, Laura Winkler, Stefan Jovinge, L. De Camp, Ovidiu Simion Cotoi
Publikováno v:
European Heart Journal. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b11473177484175ac69378bb3cc2d1fe
https://doi.org/10.1093/eurheartj/ehx504.p4026
https://doi.org/10.1093/eurheartj/ehx504.p4026